Access extends maturity on $4 million in 7% convertibles, $6 million 7.5% convertibles

By Susanna Moon

Chicago, June 11 - Access Pharmaceuticals, Inc. will extend the maturity date of two series of convertible notes, according to an 8-K filing with the Securities and Exchange Commission.

Access extended the $4 million in 7% convertibles held by Oracle Partners LP, Oracle Institutional Partners LP, SAM Oracle Investments Inc. and Oracle Offshore Ltd. to July 27 from June 12.

On June 11, the company extended its 7.5% notes due June 11 to July 26. The 7.5% convertibles with SCO Capital Partners LLC, Beach Capital LLC and Lake End Capital LLC total $6 million.

Access is a pharmaceutical company based in Dallas.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.